Terumo Co. (OTCMKTS:TRUMY) Sees Large Growth in Short Interest

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 61,900 shares, an increase of 217.4% from the March 15th total of 19,500 shares. Based on an average daily volume of 213,100 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the company's stock are short sold.

Terumo Stock Up 3.5 %

Shares of TRUMY stock traded up $0.65 during mid-day trading on Friday, reaching $19.02. 157,283 shares of the company were exchanged, compared to its average volume of 196,195. The company has a market capitalization of $28.16 billion, a P/E ratio of 39.68 and a beta of 0.76. The business's 50 day simple moving average is $18.36 and its 200 day simple moving average is $19.09. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. Terumo has a fifty-two week low of $14.06 and a fifty-two week high of $21.22.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.16 earnings per share for the quarter. The company had revenue of $1.73 billion during the quarter.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.